Objective To evaluate the effectiveness of Qingyi decoction in the treatment of severe acute pancreatitis according to a systematic review and meta-analysis. Methods Medline, EMBASE, Cochrane library (from 1966 to July 2007) and China Biological Medicine Disk (from 1978 to July 2007) were searched for articles, using the MESH headings Qingyi, traditional Chinese drug, severe acute pancreatitis, randomized controlled trial. Bibliographies of journal articles were also searched for relevant studies. Only randomized trials that compared Qingyi decoction of adjunctive therapy with control group in severe acute pancreatitis were selected. Nine studies were enrolled into the analysis. The detail about the trial design, characters of the subjects, results of the studies were reviewed by two independent authors and analyzed by using Revman 4.2 software. Results Compared with control group, the use of adjunctive therapy with Qingyi decoction group was associated with significantly lower the time of stomachache relief (WMD = -24.72, 95% CI:-35.06 ~ -14.37, P 0.01), hospital stay (days)(WMD = -9.81,95% CI: -16.23 ~ -3.39, P 0.01)and hospital death (OR = 0.27,95% CI: 0.15 ~ 0.50, P 0.01), and had the tendency of the lower incidence of complications (OR = 0.31, 95% CI:0.07 ~ 1.42, P = 0.13). The funnel plot of the studies in the meta-analysis did not show any publication bias. Conclusions The systematic review and meta-analysis show that the adjunctive therapy with Qingyi decoction in severe acute pancreatitis can benefit for decreasing the time of stomachache relief, hospital stay and the incidence of hospital death. The routine adjunctive therapy with Qingyi decoction in severe acute pancreatitis should be recommended.